About
Solutions
Pipeline
Publications
News
Careers
CN
Open main menu
News
Track Our News on
2024-04-15
MindRank Honored in Global Health & Pharma Magazine's 2024 Biotechnology Awards Winners
2024-04-02
MindRank and BioMetas Announce Strategic Partnership to Establish One-Stop Service Platform for AI+ Drug Research and Development
2024-03-20
J. Cheminform. | Automated molecular structure segmentation from documents using ChemSAM
2024-03-12
ChemRxiv | A Smart Strategy for Photoresponsive Molecules: Utilizing Generative Pre-trained Transformer and TDDFT Calculations in Drug Delivery
2024-02-27
MindRank Recognized in HolonIQ 2023 East Asia Health Tech 200
2024-02-06
MindRank Achieves Milestone in Merck China Knowledge Graph Project, Advancing New Drug R&D with Enhanced Intelligence Insights from AI Large Models
2024-01-31
Bioorganic Chemistry | Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors
2024-01-22
MindRank Founder Zhangming Niu Named in 2023 Forbes China Outstanding Foreign Talent Selection Honoree List
2024-01-19
MindRank and Henlius Announce Strategic Collaboration for AI-Driven Development of Next-Gen Antibody Drug Conjugates (ADCs) and Anti-Aging Therapy Platform
2023-11-24
Galen Growth | MindRank Features in the HealthTech 250 most promising early-stage Digital Health ventures list for 2023
2023-11-24
MindRank Founder Zhangming Niu Awarded Forbes China 100 Outstanding Overseas Returnees
2023-11-23
MindRank has Nominated Kinase Inhibitors as Preclinical Candidates with the Potential to be Best-in-Class for IND-Enabling Studies
Previous
1 / 4
Next
Previous
1 / 4
Next